News

The drug discovery collaboration will utilize Numerate’s in silico drug design technology to generate drug leads for an undisclosed cardiovascular disease target. The platform will feature a set

The liposomal delivery technology is used in the development and commercialization of DNAi-based therapeutics. As per the agreement, Marina could receive up to $14m for each gene target

The company expects to launch the product in the US in the third quarter of 2012. BINOSTO is a treatment option for those patients who have difficulty with

Mobile Intelligence solution allows Gedeon Richter Spain to exercise superior control over spending and commercial operations. The solution also provides advanced profiling, planning and targeting tools which empower

MedPodium Nutra-Apps capsules are small, sealed and come in one-and-done dosing to promote personal health and well being. Under the partnership, NPI distributes Nutra-Apps products to retail and

The company will use Mobile Intelligence for its primary care, specialty, key account management and over-the-counter commercial teams. Mobile Intelligence features an intuitive Graphic User Interface (GUI) for

The DSIMS software is a repository, unified data model, viewer and analytical tool behind the FDA’s Nonclinical Information Management Solution (NIMS). FDA reviewers will use NIMS to view,

INyDIA will provide My5-FU test kits to laboratories, enabling oncologists to individualize 5-FU dosing to optimize therapeutic efficacy and reduce toxicity for their patients. My5-FU measures levels of

The collaboration will investigate and evaluate the implementation of a pharmacogenetic program in a community pharmacy. The study involves a protocol jointly developed by Kerr Drug and UNC